Related Experiment Video
Updated: Jul 19, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
How much do we know about atopic asthma: where are we now?
Sun Ying1, Guizhen Zhang, Shuyan Gu
1King's College London, Division of Asthma, Allergy and Lung Biology, MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK. ying.sun@kcl.ac.uk
Cellular & Molecular Immunology
|November 10, 2006
Summary
Asthma is a chronic respiratory disease affecting millions globally, characterized by airway inflammation and remodeling. Current treatments are insufficient for severe cases, highlighting the need for new therapeutic strategies.
Area of Science:
- Pulmonology
- Immunology
- Pathophysiology
Background:
- Asthma is a prevalent chronic respiratory disease affecting millions worldwide, including over 3.5 million in the UK.
- It is characterized by airway hyperresponsiveness, inflammation, remodeling, and reversible obstruction, involving various inflammatory cells and mediators.
- Despite current therapies like corticosteroids, many patients experience severe, persistent symptoms, indicating a need for improved treatments.
Purpose of the Study:
- To investigate the underlying mechanisms of asthma pathogenesis.
- To identify novel therapeutic targets for severe asthma.
- To enhance understanding of airway inflammation and remodeling in asthma.
Main Methods:
- Review of current literature on asthma pathogenesis.
- Analysis of inflammatory pathways and cellular interactions in the airways.
- Evaluation of existing therapeutic approaches and their limitations.
Main Results:
- Chronic airway inflammation and remodeling are key features of asthma, leading to reduced lung function.
- The precise molecular mechanisms driving these processes are not fully understood.
- Current treatments, while effective for some, do not fully address the needs of patients with severe disease.
Conclusions:
- A deeper understanding of asthma pathogenesis is crucial for developing innovative therapies.
- Targeting airway inflammation and remodeling holds promise for managing severe asthma.
- Novel therapeutic approaches are urgently needed for patients with chronic, debilitating asthma symptoms.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...